WN D'Souza, CF Chang, AM Fischer, M Li, SM Hedrick. (2008) " The Erk2 MAPK regulates CD8 T cell proliferation and survival. " J Immunol 181. 7617-29 PMID: 19017950 | Abstract and Keywords
BS Sheridan, TL Cherpes, J Urban, P Kalinski, RL Hendricks. (2009) " Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. " J Virol 83. 2237-45 PMID: 19073721 DOI: 10.1128/JVI.01699-08 | Abstract and Keywords
I Sada-Ovalle, A Chiba, A Gonzales, MB Brenner, SM Behar. (2008) " Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. " PLoS Pathog 4. e1000239 PMID: 19079582 DOI: 10.1371/journal.ppat.1000239 | Abstract and Keywords
C Wahl, W Müller, F Leithäuser, G Adler, F Oswald, J Reimann, R Schirmbeck, A Seier, JM Weiss, B Prochnow, UM Wegenka. (2009) " IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses. " J Immunol 182. 802-10 PMID: 19124723 | Abstract and Keywords
AM Burns, L Ma, Y Li, D Yin, J Shen, J Xu, AS Chong. (2009) " Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. " J Immunol 182. 1314-24 PMID: 19155477 | Abstract and Keywords
P Thapa, G Zhang, C Xia, A Gelbard, WW Overwijk, C Liu, P Hwu, DZ Chang, A Courtney, JK Sastry, PG Wang, C Li, D Zhou. (2009) " Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. " Vaccine 27. 3484-8 PMID: 19200815 DOI: 10.1016/j.vaccine.2009.01.047 | Abstract and Keywords
CK Hu, F Venet, DS Heffernan, YL Wang, B Horner, X Huang, CS Chung, SH Gregory, A Ayala. (2009) " The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock. " J Immunol 182. 2467-75 PMID: 19201902 DOI: 10.4049/jimmunol.0801463 | Abstract and Keywords
VV Parekh, S Lalani, S Kim, R Halder, M Azuma, H Yagita, V Kumar, L Wu, LV Kaer. (2009) " PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. " J Immunol 182. 2816-26 PMID: 19234176 DOI: 10.4049/jimmunol.0803648 | Abstract and Keywords